Recent studies have indicated that 5‐HT6R may be a potential target for cognitive improvement in AD (Hu et al., 2017; Khoury et al., 2018; Ramirez, 2013), schizophrenia (de Bruin & Kruse, 2015), and other cognitive or memory deficits. Here, HTR6 is linked to schizophrenia.